{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:10:54Z","timestamp":1786983054212,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009232","name":"University of Debrecen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Endocrine disorders negatively influence the ovarian function, and increasing incidence of endocrine diseases with age may have further negative effects on pregnancy rate. Prospective cohort study of 231 consecutively enrolled patients underwent IVF treatment. In patients with known endocrine disorders, the laboratory parameters were corrected before IVF treatment. One hundred sixty one patients (69.7%) had at least one known and treated endocrine disorder (study group), and 70 patients were endocrine negative (control group). Endocrine disorders diagnosed were thyroid disorders (32.5%), diminished ovarian reserve (23.8%), insulin resistance (22.5%), PCOS (15.2%), hyperprolactinaemia (13.4%), obesity (12.1%), hypogonadotropic hypogonadism (0.8%) and congenital adrenal hyperplasia (0.2%). Before the IVF treatment, systematic endocrine laboratory examinations were performed in all patients. Higher age, BMI and FSH were found in the study group, while AMH level was lower. There were no differences in LH, E2, prolactin, TSH, FT3, FT4, TT, DHEAS, androstendione, 17-OHP and SHBG level between the study and control groups. The study group had higher baseline glucose, baseline insulin, 120-min glucose and 120-min insulin level after oral glucose tolerance test. With no difference in the IVF cycles performed, pregnancy rate was lower in the study group (61.43% vs. 34.16%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003), and this difference (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0151) remained in age-corrected rates, as well. The analyses were also performed in individual endocrinology groups. The prevalence of endocrine disorders is high in females participating in IVF programs, and they are often accompanying each other. Even after proper correction, the presence of the endocrine disorder negatively influences the pregnancy rate in IVF treatment.\n                  <\/jats:p>","DOI":"10.1007\/s43032-022-01137-0","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T11:04:45Z","timestamp":1670411085000},"page":"1878-1890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of Endocrine Disorders on IVF Outcomes: Results from a Large, Single-Centre, Prospective Study"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1894-9663","authenticated-orcid":false,"given":"Tunde","family":"Herman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Csehely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Orosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-0065","authenticated-orcid":false,"given":"Harjit Pal","family":"Bhattoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Deli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4093-3721","authenticated-orcid":false,"given":"Peter","family":"Torok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1543-2802","authenticated-orcid":false,"given":"Antonio Simone","family":"Lagana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6294-3720","authenticated-orcid":false,"given":"Vito","family":"Chiantera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2266-2297","authenticated-orcid":false,"given":"Atilla","family":"Jakab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"1137_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","volume":"62","author":"M Vander Borght","year":"2018","unstructured":"Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2\u201310. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.03.012.","journal-title":"Clin Biochem"},{"key":"1137_CR2","unstructured":"Choe J, Shanks AL. In vitro fertilization. In StatPearls. 2022. 2. Treasure Island (FL): StatPearls Publishing. Last updated September 9, 2021; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562266\/"},{"key":"1137_CR3","unstructured":"Taylor HS, Pal L, Seli E (eds). Speroff\u2019s clinical gynecologic endocrinology and infertility. 9th edn. 2020; 1104\u20131110. Wolters Kluwer\/ Lippincott Williams & Wilkins, Philadelphia, USA"},{"key":"1137_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1556\/650.2022.32372","volume":"163","author":"T Herman","year":"2022","unstructured":"Herman T, Sz C, Orosz M, Bhattoa HP, Deli T, T\u00f6r\u00f6k P, Jakab A. Prevalence and association of endocrine disorders in women participating in an in vitro fertilization program. Orv Hetil. 2022;163:712\u20139. https:\/\/doi.org\/10.1556\/650.2022.32372.","journal-title":"Orv Hetil"},{"key":"1137_CR5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1089\/thy.2006.0235","volume":"17","author":"Y Aoki","year":"2007","unstructured":"Aoki Y, Belin RM, Clickner R, et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999\u20132002). Thyroid. 2007;17:1211\u201323. https:\/\/doi.org\/10.1089\/thy.2006.0235.","journal-title":"Thyroid"},{"key":"1137_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/humupd\/dmw019","volume":"22","author":"A Busnelli","year":"2016","unstructured":"Busnelli A, Paffoni A, Fedele L, Somigliana E. The impact of thyroid autoimmunity on IVF\/ICSI outcome: a systematic review and meta-analysis. Hum Reprod Update. 2016;22:775\u201390. https:\/\/doi.org\/10.1093\/humupd\/dmw019.","journal-title":"Hum Reprod Update"},{"issue":"11","key":"1137_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13044-018-0052-y","volume":"30","author":"K Poppe","year":"2018","unstructured":"Poppe K, Veltri F, Autin C. Does levothyroxine improve pregnancy outcomes in euthyroid women with thyroid autoimmunity undergoing assisted reproductive technology? Thyroid Res. 2018;30(11):7. https:\/\/doi.org\/10.1186\/s13044-018-0052-y.","journal-title":"Thyroid Res"},{"key":"1137_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12958-020-00671-3","volume":"18","author":"A Venables","year":"2020","unstructured":"Venables A, Wong W, Way M, Homer HA. Thyroid autoimmunity and IVF\/ICSI outcomes in euthyroid women: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2020;18:120. https:\/\/doi.org\/10.1186\/s12958-020-00671-3.","journal-title":"Reprod Biol Endocrinol"},{"key":"1137_CR9","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.fertnstert.2015.05.017","volume":"104","author":"K Devine","year":"2015","unstructured":"Devine K, Mumford SL, Wu M, et al. Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril. 2015;104:612\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.05.017.","journal-title":"Fertil Steril"},{"key":"1137_CR10","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. https:\/\/doi.org\/10.1038\/nrdp.2016.57.","journal-title":"Nat Rev Dis Primers"},{"key":"1137_CR11","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1210\/jcem.83.9.5090","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078\u201382. https:\/\/doi.org\/10.1210\/jcem.83.9.5090.","journal-title":"J Clin Endocrinol Metab"},{"key":"1137_CR12","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067\u201373. https:\/\/doi.org\/10.1093\/humrep\/des232.","journal-title":"Hum Reprod"},{"key":"1137_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA. Endocrine Society Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273\u201388. https:\/\/doi.org\/10.1210\/jc.2010-1692.","journal-title":"J Clin Endocrinol Metab"},{"key":"1137_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000512790","volume":"9","author":"K Poppe","year":"2021","unstructured":"Poppe K, Bisschop P, Fugazzola L, et al. 2021 European Thyroid Association guideline on thyroid disorders prior to and during assisted reproduction. Eur Thyroid J. 2021;9:281\u201395. https:\/\/doi.org\/10.1159\/000512790.","journal-title":"Eur Thyroid J"},{"key":"1137_CR15","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1056\/NEJMcp1611144","volume":"376","author":"RP Peeters","year":"2017","unstructured":"Peeters RP. Subclinical hypothyroidism. N Engl J Med. 2017;376:2556\u201365. https:\/\/doi.org\/10.1056\/NEJMcp1611144.","journal-title":"N Engl J Med"},{"key":"1137_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/dew218","volume":"19","author":"Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137. https:\/\/doi.org\/10.1093\/humrep\/dew218.","journal-title":"Hum Reprod"},{"key":"1137_CR17","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, et al. Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565\u201392. https:\/\/doi.org\/10.1210\/jc.2013-2350.","journal-title":"J Clin Endocrinol Metab"},{"key":"1137_CR18","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ. International PCOS Network Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33:1602\u201318. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.05.004.","journal-title":"Hum Reprod"},{"key":"1137_CR19","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE working group on poor ovarian response definition. ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616\u201324. https:\/\/doi.org\/10.1093\/humrep\/der092.","journal-title":"Hum Reprod"},{"key":"1137_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.fertnstert.2010.08.047","volume":"95","author":"B Almog","year":"2011","unstructured":"Almog B, Shehata F, Shalom-Paz E, et al. Age-related normogram for antral follicle count: McGill reference guide. Fertil Steril. 2011;95:663\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.08.047.","journal-title":"Fertil Steril"},{"key":"1137_CR21","unstructured":"Taylor HS, Pal L, Seli E (eds.) Speroff\u2019s clinical gynecologic endocrinology and infertility. 9th edn. 2020; 453\u2013454. Wolters Kluwer\/ Lippincott Williams & Wilkins, Philadelphia, USA"},{"key":"1137_CR22","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1556\/650.2022.32372","volume":"163","author":"T Herman","year":"2022","unstructured":"Herman T, Sz C, Orosz M, Bhattoa HP, Deli T, T\u00f6r\u00f6k P, Jakab A. Prevalence and association of endocrine disorders in women participating in an in vitro fertilization program. Orv Hetil. 2022;163:712\u20139. https:\/\/doi.org\/10.1556\/650.2022.32372.","journal-title":"Orv Hetil"},{"key":"1137_CR23","unstructured":"Taylor HS, Pal L, Seli E (eds.) Speroff\u2019s clinical gynecologic endocrinology and infertility. 9th edn. 2020; 1108. Wolters Kluwer\/ Lippincott Williams & Wilkins, Philadelphia, USA"},{"key":"1137_CR24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S1701-2163(16)35087-3","volume":"33","author":"K Liu","year":"2011","unstructured":"Liu K, Case A. Reproductive Endocrinology and Infertility Committee Advanced reproductive age and fertility. J Obstet Gynaecol Can. 2011;33:1165\u201375. https:\/\/doi.org\/10.1016\/S1701-2163(16)35087-3.","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"1137_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161365.GL","volume":"22","author":"WT Garvey","year":"2016","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R. Reviewers of the AACE\/ACE Obesity Clinical Practice Guidelines American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(3):1\u2013203. https:\/\/doi.org\/10.4158\/EP161365.GL.","journal-title":"Endocr Pract"},{"key":"1137_CR26","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s10815-015-0595-y","volume":"32","author":"J Cohen","year":"2015","unstructured":"Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder\u2013a plea for universal definitions. J Assist Reprod Genet. 2015;32:1709\u201312. https:\/\/doi.org\/10.1007\/s10815-015-0595-y.","journal-title":"J Assist Reprod Genet"},{"key":"1137_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/09513590.2019.1653564","volume":"35","author":"GK Safarian","year":"2019","unstructured":"Safarian GK, Gzgzyan AM, Dzhemlikhanova Lyailya K, Niauri DA. Does subclinical hypothyroidism and\/or thyroid autoimmunity influence the IVF\/ICSI outcome? Review of the literature Gynecol Endocrinol. 2019;35:56\u20139. https:\/\/doi.org\/10.1080\/09513590.2019.1653564.","journal-title":"Review of the literature Gynecol Endocrinol"},{"key":"1137_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/GCO.0000000000000263","volume":"28","author":"G Mintziori","year":"2016","unstructured":"Mintziori G, Goulis DG, Kolibianakis EM. Thyroid function and IVF outcome: when to investigate and when to intervene. Curr Opin Obstet Gynecol. 2016;28:191\u20137. https:\/\/doi.org\/10.1097\/GCO.0000000000000263.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1137_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1023\/a:1024151210536","volume":"20","author":"DW Cramer","year":"2003","unstructured":"Cramer DW, Sluss PM, Powers RD, McShane P, Ginsburgs ES, Hornstein MD, Vitonis AF, Barbieri RL. Serum prolactin and TSH in an in vitro fertilization population: is there a link between fertilization and thyroid function. J Assist Reprod Genet. 2003;20:210\u20135. https:\/\/doi.org\/10.1023\/a:1024151210536.","journal-title":"J Assist Reprod Genet"},{"key":"1137_CR30","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/humupd\/dmw019","volume":"22","author":"A Busnelli","year":"2016","unstructured":"Busnelli A, Paffoni A, Fedele L, Somigliana E. The impact of thyroid autoimmunity on IVF\/ICSI outcome: a systematic review and meta-analysis. Hum Reprod Update. 2016;22:775\u201390. https:\/\/doi.org\/10.1093\/humupd\/dmw019.","journal-title":"Hum Reprod Update"},{"key":"1137_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","volume":"228","author":"Y Li","year":"2019","unstructured":"Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, Wu D. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019;228:167\u201375. https:\/\/doi.org\/10.1016\/j.lfs.2019.04.046.","journal-title":"Life Sci"},{"key":"1137_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tem.2019.04.006","volume":"30","author":"H Teede","year":"2019","unstructured":"Teede H, Misso M, Tassone EC, Dewailly D, Ng EH, Azziz R, Norman RJ, Andersen M, Franks S, Hoeger K, Hutchison S, Oberfield S, Shah D, Hohmann F, Ottey S, Dabadghao P, Laven JSE. Anti-M\u00fcllerian hormone in PCOS: a review informing international guidelines. Trends Endocrinol Metab. 2019;30:467\u201378. https:\/\/doi.org\/10.1016\/j.tem.2019.04.006.","journal-title":"Trends Endocrinol Metab"},{"key":"1137_CR33","doi-asserted-by":"publisher","first-page":"e023413","DOI":"10.1136\/bmjopen-2018-023413","volume":"8","author":"LN Vuong","year":"2018","unstructured":"Vuong LN, Ho VNA, Ho TM, Dang VQ, Phung TH, Giang NH, Le AH, Pham TD, Wang R, Norman RJ, Smitz J, Gilchrist RB, Mol BW. Effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilisation in women with high antral follicle count: study protocol for a randomised controlled trial. BMJ Open. 2018;8:e023413. https:\/\/doi.org\/10.1136\/bmjopen-2018-023413.","journal-title":"BMJ Open"},{"key":"1137_CR34","doi-asserted-by":"publisher","unstructured":"European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod.\u00a02016;31(5):926\u201337. https:\/\/doi.org\/10.1093\/humrep\/dew027","DOI":"10.1093\/humrep\/dew027"},{"key":"1137_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fendo.2020.00192","volume":"11","author":"Z Blumenfeld","year":"2020","unstructured":"Blumenfeld Z. What is the best regimen for ovarian stimulation of poor responders in ART\/IVF. Front Endocrinol (Lausanne). 2020;11:192. https:\/\/doi.org\/10.3389\/fendo.2020.00192.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1137_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5468\/ogs.2017.60.1.46","volume":"60","author":"BH Yun","year":"2017","unstructured":"Yun BH, Kim G, Park SH, Noe EB, Seo SK, Cho S, Choi YS, Lee BS. In vitro fertilization outcome in women with diminished ovarian reserve. Obstet Gynecol Sci. 2017;60:46\u201352. https:\/\/doi.org\/10.5468\/ogs.2017.60.1.46.","journal-title":"Obstet Gynecol Sci"},{"key":"1137_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fendo.2019.00281","volume":"10","author":"V Grisendi","year":"2019","unstructured":"Grisendi V, Mastellari E, La Marca A. Ovarian reserve markers to identify poor responders in the context of Poseidon classification. Front Endocrinol (Lausanne). 2019;10:281. https:\/\/doi.org\/10.3389\/fendo.2019.00281.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1137_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12884-018-1783-4","volume":"18","author":"A Kamel","year":"2018","unstructured":"Kamel A, Halim AA, Shehata M, AlFarra S, El-Faissal Y, Ramadan W, Hussein AM. Changes in serum prolactin level during intracytoplasmic sperm injection, and effect on clinical pregnancy rate: a prospective observational study. BMC Pregnancy Childbirth. 2018;18:141. https:\/\/doi.org\/10.1186\/s12884-018-1783-4.","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01137-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-022-01137-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-022-01137-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:05:05Z","timestamp":1685451905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-022-01137-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1007\/s43032-022-01137-0","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UD CC REC\/IEC No. 5684\u20132021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All the authors have consented to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}